Hot Stocks
Monday, August 1, 2016
UPDATE 1-Biogen pays Ionis $75 mln to develop muscle drug after trial success
Aug 1 (Reuters) - Biogen Inc said it would exercise
an option to develop and commercialize an experimental genetic
muscle-disorder drug after an interim analysis of late-stage
data showed patients...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment